SNY FY 2017 Earnings Report — Sanofi Revenue & Financial Results | Market Cap Arena

FY 2017 Earnings

Reported December 30, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2017	Prior Q	FY 2016	QoQ Change	YoY Change
Revenue	$42.3B	—	$40.6B	—	4.4%
Op. Income	$6.8B	—	$7.6B	—	-11.1%
Gross Margin	67.9%	—	69.2%	—	-1.2pp
Net Margin	23.2%	—	13.6%	—	9.7pp
EPS (Diluted)	$3.93	—	$2.14	—	83.6%
Free Cash Flow	$6.3B	—	$6.7B	—	-5.8%

Revenue Flow

Item	Amount
REVENUE	$42.3B
Cost of Revenue	$13.6B
GROSS PROFIT	$28.8B
R&D Expenses	$6.4B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$11.8B
Other Expenses	$3.8B
Operating Expenses	$22.0B
Cost & Expenses	$35.6B
OPERATING INCOME	$6.8B
Interest Income	$63M
Interest Expense	$390M
Other Income/Expenses	-$220M
INCOME BEFORE TAX	$6.6B
Income Tax Expense	$2.0B
Net Income from Continuing Ops	$4.6B
Net Income from Discontinued Ops	$5.4B
Other Adjustments	$0
NET INCOME	$9.8B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$9.8B
D&A	$4.3B
EBIT	$7.0B
EBITDA	$11.3B
EPS	$2
EPS Diluted	$4

Income Statement

Item	Amount
REVENUE	$42.3B
Cost of Revenue	$13.6B
GROSS PROFIT	$28.8B
R&D Expenses	$6.4B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$11.8B
Other Expenses	$3.8B
Operating Expenses	$22.0B
Cost & Expenses	$35.6B
OPERATING INCOME	$6.8B
Interest Income	$63M
Interest Expense	$390M
Other Income/Expenses	-$220M
INCOME BEFORE TAX	$6.6B
Income Tax Expense	$2.0B
Net Income from Continuing Ops	$4.6B
Net Income from Discontinued Ops	$5.4B
Other Adjustments	$0
NET INCOME	$9.8B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$9.8B
D&A	$4.3B
EBIT	$7.0B
EBITDA	$11.3B
EPS	$2
EPS Diluted	$4

Cash Flow Statement

Item	Amount
Net Income	$9.9B
Depreciation & Amortization	$4.3B
Stock-Based Compensation	$307M
Deferred Income Tax	-$1.1B
Other Non-Cash Items	-$4.7B
Change in Working Capital	$173M
OPERATING CASH FLOW	$8.6B
Capital Expenditure	-$2.3B
Acquisitions (Net)	-$1.3B
Purchases of Investments	-$188M
Sales/Maturities of Investments	$0
Other Investing Activities	$4.6B
NET CASH FROM INVESTING	$747M
Net Debt Issuance	-$2.7B
Common Stock Repurchased	-$2.5B
Common Dividends Paid	-$4.3B
Other Financing Activities	-$18M
NET CASH FROM FINANCING	-$9.2B
FREE CASH FLOW	$6.3B
Net Change in Cash	$49M

Balance Sheet

Item	Amount
Cash & Equivalents	$12.1B
Short-Term Investments	$0
Net Receivables	$10.1B
Inventory	$8.0B
Other Current Assets	$246M
TOTAL CURRENT ASSETS	$30.8B
PP&E (Net)	$11.2B
Goodwill	$47.1B
Intangible Assets	$15.3B
Long-Term Investments	$7.2B
Tax Assets	$5.0B
Other Non-Current Assets	$122M
TOTAL NON-CURRENT ASSETS	$85.9B
TOTAL ASSETS	$116.7B
Account Payables	$5.4B
Short-Term Debt	$1.5B
Deferred Revenue	$0
Other Current Liabilities	$7.5B
TOTAL CURRENT LIABILITIES	$18.1B
Long-Term Debt	$16.7B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$1.9B
Other Non-Current Liabilities	$11.9B
TOTAL NON-CURRENT LIABILITIES	$30.5B
TOTAL LIABILITIES	$48.6B
Common Stock	$2.9B
Additional Paid-In Capital	$0
Retained Earnings	$61.8B
Treasury Stock	-$16M
Accum. Other Comp. Income	$3.2B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$67.9B
Minority Interest	$198M
TOTAL EQUITY	$68.1B
TOTAL LIABILITIES & EQUITY	$116.7B
Total Debt	$18.2B
Net Debt	$6.2B